Enteral stents market is a leading non-vascular stents market. This market includes esophageal stents, gastro duodenal stents, and colonic stents, and is divided into three segments: fully covered enteral stents, partially covered enteral stents, and non-covered enteral stents. As a whole, the enteral stents market is increasing, primarily due to globally rising cancer rates, specifically esophageal, stomach, pancreatic, and colorectal cancers, and by an increased awareness of stenting as a palliative treatment.
Globally, fully covered stents are the largest of the enteral stent markets. They tend to be preferred over partially covered and non-covered enteral stents, especially in the case of esophageal stents, as they have the lowest risk of tumor or tissue ingrowth. The non-covered enteral stents market, however, is a declining market, as they are more likely to result in tumor ingrowth and result in further complications. This trend is seen throughout the global enteral stents market.
Global enteral stents market was valued at $172.3M in 2016 and is expected to grow at a CAGR of 3.70% to reach a value of $222.1M in 2023.
The key drivers of this market during the forecast period are:
- Increased cancer rates driven by an increased intake of toxins such as tobacco and alcohol.
- Increase in diseases such as diabetes, as well as obesity.
- Development of stenting technology.
Both North and South American Enteral stents market is expected to grow at a CAGR of 4.2% followed by APAC at a CAGR of 3.5%, Middle Eastern and Africa, Europe at 3.3% and 3.4% respectively.
Enteral stents are a palliative treatment option for constrictions caused primarily by various cancers. The primary cancers which cause constrictions requiring the use of enteral stents are esophageal cancer, gastric cancer, pancreatic cancer, and colorectal cancer. There are three primary enteral stents; the covered enteral stent, the partially covered enteral stents, and the non-covered enteral stent.
There are three key players in the international enteral stents market. Boston Scientific is the leading company in the enteral stents market thanks to an extensive product line and a presence in all segments of the enteral stents market. Its presence was further strengthened by the acquisition of EndoChoice, a former smaller player in the enteral stents market. The other two key players in the enteral stents market are Cook Medical and Taewoong Medical. Cook Medical has established a strong presence despite a small product line, while Taewoong Medical has a more extensive product portfolio.
The report "MediPoint: Enteral Stents - Global Analysis and Market Forecasts" examines the enteral stents market globally. This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed products, current players, as well as market outlooks in the Global market.
Companies mentioned in this report: Boston Scientific, EndoChoice, Taewoong Medical, Cook Medical. Merit Medical, Leufen Medical, ELLA-CS, M.I.Tech.
*Note: This is an on-demand report and will be delivered within 3 working days (excluding weekends) of the purchase.
- Outlook of sales volume, pricing trends, revenue trends with 2016 as base year and forecasts until 2023, for fully covered, partially covered and non - covered enteral stents.
- Company share analysis in 2016, for enteral stents.
- Market insights and competitive assessment of the key players within enteral stents market.
Reasons to buy
- Identify the unmet needs and understand hospitals’ perceptions of the current enteral stents market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global enteral stents market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors.
2 Executive Summary
2.2 Market Dynamics
2.3 Key Players
2.4 Future Outlook
3.2 Related Reports
3.3 Upcoming Related Reports
4 Market Outlook
4.1 Procedure Trends
4.2 Pricing Trends
4.3 Revenue Trends
4.4 Company Share Analysis
5 Market Insights
5.1 North America
5.2.1 Denmark, Finland, Norway, and Sweden
5.2.2 Belgium, France, and Netherlands
5.2.3 Austria, Germany, and Switzerland
5.2.4 UK and Ireland
5.2.5 Italy, Portugal, and Spain
5.2.6 Czech Republic, Hungary, and Poland
5.2.7 Russia, Turkey, and Greece
5.3.1 Australia & New Zealand
5.3.2 China & Taiwan
5.3.5 South Korea
5.4 South America
5.4.2 Argentina & Chile
5.5 Middle East and Africa
5.5.2 South Africa
5.5.3 Egypt, Saudi Arabia, and UAE
6 Competitive Assessment
6.1 Boston Scientific
6.1.2 Portfolio Assessment
6.1.3 Deal Analysis
6.1.4 Competitive Positioning
6.2 Cook Medical
6.2.2 Portfolio Assessment
6.2.3 Competitive Positioning
6.3 Taewoong Medical
6.3.2 Portfolio Assessment
6.3.3 Competitive Positioning
6.4 Other Players
7.3.3 Secondary Research
7.3.4 Forecasting Methodology
7.3.5 Primary Research Summary
7.4 About the Authors
7.4.2 Global Head of Medical Devices
7.5 About MediPoint
List of Tables
Table 1: Key Metrics in the North America Market
Table 2: North America Enteral Stenting Procedure Volume Forecast, 2014-2023
Table 3: North America Enteral Stents Average Selling Price ($) Forecast, 2014-2023
Table 4: North America Enteral Stents Sales Forecast ($M), 2014-2023
Table 5: North America Company Share Analysis, 2016
Table 6: Key Metrics in the Europe Market
Table 7: Europe Enteral Stenting Procedure Volume Forecast, 2014-2023
Table 8: Europe Enteral Stents Average Selling Price ($) Forecast, 2014-2023
Table 9: Europe Enteral Stents Sales Forecast ($M), 2014-2023
Table 10: Europe Company Share Analysis, 2016
Table 11: Key Metrics in the Asia Pacific Market
Table 12: Asia Pacific Enteral Stenting Procedure Volume Forecast, 2014-2023
Table 13: Asia Pacific Enteral Stents Average Selling Price ($) Forecast, 2014-2023
Table 14: Asia Pacific Enteral Stents Sales Forecast ($M), 2014-2023
Table 15: Asia Pacific Company Share Analysis, 2016
Table 16: Key Metrics in the South America Market
Table 17: South America Enteral Stenting Procedure Volume Forecast, 2014-2023
Table 18: South America Enteral Stents Average Selling Price ($) Forecast, 2014-2023
Table 19: South America Enteral Stents Sales Forecast ($M), 2014-2023
Table 20: South America Company Share Analysis, 2016
Table 21: Key Metrics in the Middle East and Africa Market
Table 22: Middle East and Africa Enteral Stenting Procedure Volume Forecast, 2014-2023
Table 23: Middle East and Africa Enteral Stents Average Selling Price ($) Forecast, 2014-2023
Table 24: Middle East and Africa Enteral Stents Sales Forecast ($M), 2014-2023
Table 25: Middle East and Africa Company Share Analysis, 2016
Table 26: Product Portfolio - Boston Scientific
Table 27: Product Portfolio - Cook Medical
Table 28: Product Portfolio -Taewoong Medical
Table 29: Other Players Assessment
List of Figures
Figure 1: Enteral Stents Sales for North America by Country, 2016 and 2023
Figure 2: Enteral Stents Sales for Europe by Country, 2016 and 2023
Figure 3: Enteral Stents Sales for Asia Pacific by Country, 2016 and 2023
Figure 4: Enteral Stents Sales for South America by Country, 2016 and 2023
Figure 5: Enteral Stents Sales for Middle East and Africa by Country, 2016 and